메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

ACROBiosystems and DAAN Biotherapeutics Sign Strategic MOU for the Development of Precision Immuno-Oncology Therapeutics

SEOUL, South Korea, Aug. 28, 2025 -- ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced that it has entered into a strategic Memorandum of Understanding (MOU) with DAAN Biotherapeutics, a clinical-stage biotech focused on precision immuno-oncology therapeutics. Through this agreement, the two companies will establish a multi-faceted collaboration framework including stable supply of high-performance bioreagents, technical cooperation for immuno-oncology drug development, and joint resea
- 김갑성 기자
- 2025-08-28 09:54
DSC® Launches DREAMCELL® VELO at The Materials Show: Redefining Speed, Agility, & Energy Return

DREAMCELL® VELO is the Lightest, Fastest, Most Responsive Poured PU Insole Technology for Performance Footwear PORTLAND, Ore., Aug. 28, 2025 -- DSC®, a global leader in high-performance foam innovation, introduces DREAMCELL® VELO, an ultra-lightweight, poured polyurethane (PU) insole technology engineered to give athletes a powerful edge in speed, agility, and explosive energy return. Debuting at The Materials Show, DREAMCELL® VELO uniquely outperforms traditional poured PU insoles with its ultra lightweight and low compression set engineered to preserve energy transfe
- 황정호 기자
- 2025-08-28 09:14
Cathay United Bank Signs Tripartite MOU with PEZA and RCBC to Support Corporate Expansion into the Philippines

MANILA, Philippines, Aug. 28, 2025 -- On August 18, Cathay United Bank (CUB) Manila Branch signed a tripartite Memorandum of Understanding for "Taiwan-Philippines Investment Promotion" with the Philippine Economic Zone Authority (PEZA)[1] and Rizal Commercial Banking Corporation (RCBC)[2]. Under the partnership, CUB and RCBC will serve as investment promotion partners, jointly organizing business forums and seminars to help enterprises identify investment opportunities, while PEZA will provide support with site selection and network building—accelerating the investment process of ov
- 황정호 기자
- 2025-08-28 09:00
Fujitsu develops AI agent platform for the healthcare sector to enhance operational efficiency and ensure stable medical service provision

TOKYO, Aug. 28, 2025 -- Fujitsu today announced the development of a secure and efficient AI agent platform to accelerate operational efficiency and ensure stable medical service provision in Japan's healthcare sector. The new platform includes an orchestrator AI agent, a centralized system that supports the collaboration and coordination of multiple specialized healthcare-specific agents developed by Fujitsu and other partner companies. The initiative aims to contribute to the rapid implementation of world-leading medical operational practices, thereby driving business transformation and imp
- 김갑성 기자
- 2025-08-28 08:40
MagMutualがAppianで業務改革

AppianのAIを活用したプラットフォームで保険契約の移行時間を削減見積り速度を向上させ業務運用を統一米バージニア州MCLEAN, 2025年8月28日 -- Appian (NASDAQ: APPN) は本日、 MagMutual社がAppianのAIを活用したプラットフォームを使って業務オペレーションの変革を成功させたことを発表しました。MagMutualは、全米4万以上の医療機関や組織に総合的な保険を提供する、医療過誤保険のリーディングプロバイダーです。同社はAppianやXebiaと提携し、基幹プロセスのモダナイズと保険契約者のエクスペリエンスの向上に取り組んでいます。 MagMutualは、レガシーシステムと手作業のワークフローに起因する問題に直面していました。見積りの作成に時間がかかる上、プロセスが断片化されていました。また、サイロ化されたシステムによって運用の可視性と応答性が損なわれ、買収に伴う保険契約の移行には最大3年かかったこともありました。「見積りのポータルを公開してから数時間以内に保険契約が成立し、広告を打たなくても非常に短期間で 100 万ドルの収益を達成しました」と、MagMutualの最高顧客責任者Mark Poling氏は述べています。 MagMutualは、Appianと
- 황정호 기자
- 2025-08-28 08:00
AIM Vaccine Forecasts Surge in Stock Performance: Innovations Reinforce Leadership in Vaccine Sector

HONG KONG, Aug. 28, 2025 -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced today the release of its 2025 interim report, showcasing robust revenue growth. With major products entering the market phase, R&D costs are decreasing, and operational expenditures are being optimized. Four core innovative products are poised for commercialization, and significant advancements have been made in overseas market expansion. Two mRNA technology vaccines have simultaneously received clinical trial approvals in both the PRC and the U.S., leading to optimistic forecasts from instit
- 김갑성 기자
- 2025-08-28 07:45
Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study

- ASC30 oral once-daily tablet demonstrated approximately 2.3-fold to 3.3-fold greater drug exposure than orforglipron in a cross-trial comparison. - Higher drug exposure and favorable tolerability profile positions ASC30 oral once-daily tablet favorably compared to orforglipron. - Topline data from the Ascletis' U.S. Phase IIa study for ASC30 in participants with obesity or overweight are expected in the fourth quarter of 2025. HONG KONG, Aug. 28, 2025 -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") today announces promising topline ph
- 김갑성 기자
- 2025-08-28 07:45
SK hynix Starts Supplying Mobile DRAM with Highly Efficient Heat Dissipation

[ 메디채널 김장윤(JASON KIM) 기자 ] Company first in industry to develop High-K EMC material, improves thermal conductivity by 3.5 times, thermal resistance by 47% Customers expect achievement to help address heat issue generated from on-device AI SK hynix to lead next-generation DRAM for mobile device through technological innovation of materials SEOUL, South Korea, Aug. 28, 2025 -- SK hynix Inc. (or "the company", www.skhynix.com) announced today that it has started supplying mobile DRAM products with highly efficient heat dissipation by adopting the High-K Epoxy Molding Com
- 김장윤(JASON KIM) 기자
- 2025-08-28 07:30
Henan Launches Global Digital Tourism Platform at Expo 2025 Osaka to Grow Inbound Visitation

TOKYO, Aug. 27, 2025 -- On August 21, 2025, the Culture and Tourism Department of Henan Province introduced its new global digital tourism platform—"Journey of Civilization Light"—in Japan during Expo 2025 Osaka. The launch represents a major step forward in strengthening international cultural and tourism exchange. During Henan Week at the Expo, more than one thousand promotional brochures and themed giveaways were shared through interactive activities, sparking interest among attendees. Journey of Civilization Light is a digital showcase designed to highlight Henan'
- 김장윤(JASON KIM) 기자
- 2025-08-28 06:32
Manny Halley Greenlights "True to the Game" TV Series

[ 메디채널 김장윤(JASON KIM) 기자 ] Series is Based on New York Times Best Selling Novel and Expands the Popular "True the Game" Franchise Beyond the Feature Film Trilogy LOS ANGELES, Aug. 28, 2025 -- Manny Halley (True to the Game, Dutch, SoulMates) is expanding the popular True to the Game franchise, making a new TV series adapted from Terri Woods' New York Times best-selling book series, that will star Sierra Capri (On My Block), Bentley Green (White Men Can't Jump), Vivica A. Fox (Independence Day), Angell Conwell (The Young and the Restless) and Carl Anthony Payne II (Martin, Y
- 김장윤(JASON KIM) 기자
- 2025-08-28 04:13

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-09-05_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 05일 23시 20분